Candel Therapeutics, Inc. Candel Therapeutics, Inc.

Candel Therapeutics, Inc.

CADL

Rank in Stocks #12811
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in... Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade glioma. Furthermore, the company is advancing CAN-3110, an investigational therapy currently in Phase I clinical trials for recurrent glioblastoma. Established in 2003, the company operated as Advantagene, Inc. until November 2020, when it rebranded as Candel Therapeutics, Inc.
Share Price
$5.40
Last synced: 2026-11-17
Market Cap
$417.88M
Change (1 day)
-7.06%
Change (1 year)
22.17%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Candel Therapeutics, Inc. (CADL)

Category

Healthcare
Operating Margin for Candel Therapeutics, Inc. (CADL)
Operating Margin as of November 2026 TTM: 0.00%
According to Candel Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Candel Therapeutics, Inc. from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% -100.00%
2022 -27,777.60% 34.97%
2021 -20,580.80% 86.29%
2020 -11,048.00% 52.82%
2019 -7,229.60% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Candel Therapeutics, Inc.'s operating margin

What was Candel Therapeutics, Inc.'s operating margin in 2025?

In 2025, Candel Therapeutics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.

How has Candel Therapeutics, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Candel Therapeutics, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2022 (-27,777.60%).

How does Candel Therapeutics, Inc.'s operating margin compare with similar companies?

Candel Therapeutics, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.